Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE
6.1. Overview
6.2. Reagent Based
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.1. Detergent
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2. Enzymatic
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Physical Disruption
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.1. Mechanical Homogenization
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.2. Ultrasonic Homogenization
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.3. Pressure Homogenization
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.4. Temperature Treatments
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT
7.1. Overview
7.2. Consumables
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1. Reagents and Kits
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2. Beads
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.3. Disposables
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Instruments
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.1. Sonicators
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.2. Homogenizers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.3. French Press
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.4. Microfluidizer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE
8.1. Overview
8.2. Mammalian Cells
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Microbial Cells
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USER
9.1. Overview
9.2. Research Laboratories and Institutes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.2.1.
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
10. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Cell Lysis & Disruption Market
11.5. Competitive Benchmarking
11.6. Leading Players in terms of Number of Developments in the Global Cell Lysis & Disruption Market
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix & Market Ratio
11.8.1. Sales & Operating Income 2020
11.8.2. Major Players R&D Expenditure 2020
11.9. Major Players Capital Market Ratio
12. COMPANY PROFILES
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Type Overview
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Merck KGAA
12.2.1. Company Overview
12.2.2. Product Type Overview
12.2.3. Financial Overview
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Product Type Overview
12.3.3. Financial Overview
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Danaher Corporation
12.4.1. Company Overview
12.4.2. Product Type Overview
12.4.3. Financial Overview
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Becton Dickinson & Company
12.5.1. Company Overview
12.5.2. Product Type Overview
12.5.3. Financial Overview
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Cell Signaling Technology, Inc.
12.6.1. Company Overview
12.6.2. Product Type Overview
12.6.3. Financial Overview
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Miltenyi Biotec
12.7.1. Company Overview
12.7.2. Product Type Overview
12.7.3. Financial Overview
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. F. Hoffmann–La Roche Ltd
12.8.1. Company Overview
12.8.2. Product Type Overview
12.8.3. Financial Overview
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Qiagen NV
12.9.1. Company Overview
12.9.2. Product Type Overview
12.9.3. Financial Overview
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Qsonica, LLC
12.10.1. Company Overview
12.10.2. Product Type Overview
12.10.3. Financial Overview
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Others
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL CELL LYSIS & DISRUPTION MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL CELL LYSIS & DISRUPTION MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 7 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 10 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 11 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 12 US: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 13 US: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 14 US: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 15 US: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 16 CANADA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 17 CANADA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 18 CANADA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 19 CANADA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 20 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 21 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 22 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 23 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 24 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 25 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 26 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 27 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 28 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 29 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 30 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 31 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 32 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 33 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 34 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 35 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 36 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCES
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CELL LYSIS & DISRUPTION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CELL LYSIS & DISRUPTION MARKET
FIGURE 4 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY TECHNIQUE, 2020 (%)
FIGURE 5 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 6 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY CELL TYPE, 2020 (%)
FIGURE 7 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY END USER, 2020 (%)
FIGURE 8 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 AMERICAS: CELL LYSIS & DISRUPTION MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: CELL LYSIS & DISRUPTION MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL CELL LYSIS & DISRUPTION MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIALS
FIGURE 16 THERMO FISHER SCIENTIFIC, INC.: SEGMENTAL REVENUE
FIGURE 17 THERMO FISHER SCIENTIFIC, INC.: REGIONAL REVENUE
FIGURE 18 MERCK KGAA: KEY FINANCIALS
FIGURE 19 MERCK KGAA: SEGMENTAL REVENUE
FIGURE 20 MERCK KGAA: REGIONAL REVENUE
FIGURE 21 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS
FIGURE 22 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUES
FIGURE 23 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE
FIGURE 24 DANAHER CORPORATION: KEY FINANCIALS
FIGURE 25 DANAHER CORPORATION: SEGMENTAL REVENUE
FIGURE 26 DANAHER CORPORATION: REGIONAL REVENUE
FIGURE 27 BECTON DICKINSON & COMPANY: KEY FINANCIALS
FIGURE 28 BECTON DICKINSON & COMPANY: SEGMENTAL REVENUE
FIGURE 29 BECTON DICKINSON & COMPANY: REGIONAL REVENUE
FIGURE 30 CELL SIGNALING TECHNOLOGY, INC.: KEY FINANCIALS
FIGURE 31 CELL SIGNALING TECHNOLOGY, INC.: SEGMENTAL REVENUE
FIGURE 32 CELL SIGNALING TECHNOLOGY, INC.: REGIONAL REVENUE
FIGURE 33 MILTENYI BIOTEC: KEY FINANCIALS
FIGURE 34 MILTENYI BIOTEC: SEGMENTAL REVENUE
FIGURE 35 MILTENYI BIOTEC: REGIONAL REVENUE
FIGURE 36 F. HOFFMANN–LA ROCHE LTD: KEY FINANCIALS
FIGURE 37 F. HOFFMANN–LA ROCHE LTD: SEGMENTAL REVENUE
FIGURE 38 F. HOFFMANN–LA ROCHE LTD: REGIONAL REVENUE
FIGURE 39 QIAGEN NV: KEY FINANCIALS
FIGURE 40 QIAGEN NV: SEGMENTAL REVENUE
FIGURE 41 QIAGEN NV: REGIONAL REVENUE
FIGURE 42 QSONICA, LLC: KEY FINANCIALS
FIGURE 43 QSONICA, LLC: SEGMENTAL REVENUE
FIGURE 44 QSONICA, LLC: REGIONAL REVENUE